Discover 2,551 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,551
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
for
Lupus Nephritis
Location: San Francisco CA, Loma Linda CA, Aurora CO,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 5 - 17
Code: NCT05039619
Phase 2, Recruiting
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
for
Methylmalonic Acidemia
Location: Palo Alto CA, Los Angeles CA, San Diego CA, Edmonton,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 1+
Code: NCT05295433
Phase 1, Phase 2, Recruiting
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
for
Epstein-Barr Virus Infections,
Location: San Francisco CA, Los Angeles CA, St Louis MO,
Sponsor: New York Medical College
Sex: All
Age: 0 - 70+
Code: NCT03266653
Phase 2, Recruiting
Exercise and Movement to Enhance Resiliency in Cancer Patients
for
Gynecologic Cancer
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: Female
Age: 18+
Code: NCT06809933
Recruiting
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: San Francisco CA, Fresno CA, Sylmar CA, Los Angeles CA,
Sponsor: Origin Inc.
Sex: All
Age: 22 - 70+
Code: NCT03078933
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Location: San Francisco CA, Orange CA, Portland OR,
Sponsor: Cabaletta Bio
Sex: All
Age: 6 - 70+
Code: NCT06154252
Phase 2, Phase 3, Recruiting
Autologous Gene Therapy for Artemis-Deficient SCID
for
Severe Combined Immunodeficiency
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 0+
Code: NCT03538899
Phase 1, Phase 2, Recruiting
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: San Francisco CA, Santa Monica CA, Los Angeles CA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 12 - 70+
Code: NCT03715933
Phase 1, Recruiting
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
for
Sensorineural Hearing Loss, Bilateral
Location: San Francisco CA, Iowa City IA, Nashville TN
Sponsor: Eli Lilly and Company
Sex: All
Age: 0+
Code: NCT05821959
Phase 3, Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Location: Stanford CA, Portland OR, Seattle WA, Missoula MT,
Sponsor: Medtronic Vascular
Sex: All
Age: 18+
Code: NCT06535854
Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
for
Renal Cell Carcinoma
Location: San Francisco CA, Nashville TN, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07049926
Phase 1, Phase 2, Recruiting
DETECT-RPC Universal EM Screening
for
Elder Abuse, Elder Mistreatment
Location: San Francisco CA, Dallas TX, Houston TX, Birmingham AL,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT05958654
Recruiting
COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation
for
Atrial Fibrillation, Abnormal Heart Rhythms
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 21 - 70+
Code: NCT02997254
Recruiting
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
for
Follicular Lymphoma, Diffuse Large B Cell Lymphoma,